Drug Profile
BI 54903/tiotropium bromide
Alternative Names: Tiotropium bromide/BI 54903Latest Information Update: 17 Mar 2017
Price :
$50
*
At a glance
- Originator Boehringer Ingelheim
- Class Antiasthmatics; Antibronchitics; Small molecules; Tropanes
- Mechanism of Action Muscarinic M1 receptor antagonists; Muscarinic M3 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Asthma; Respiratory tract disorders
Most Recent Events
- 16 Mar 2017 Discontinued - Phase-I for Respiratory tract disorders (In volunteers) in Germany before March 2017 (Inhalation)
- 16 Mar 2017 Discontinued - Phase-II for Asthma in Slovakia before March 2017 (Inhalation)
- 16 Jul 2016 No recent reports of development identified for phase-I development in Respiratory-tract-disorders(In volunteers) in Germany (Inhalation, Powder)